Transcriptomics

Dataset Information

0

ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen


ABSTRACT: ATM gene mutation carriers are predisposed to estrogen receptor (ER)-positive breast cancer (BC). ATM prevents BC oncogenesis by activating p53 in every cell; however, much remains unknown about tissue-specific oncogenesis following ATM loss. Here, we report that ATM controls the early transcriptional response to estrogens. This response depends on topoisomerase II (TOP2), which generates TOP2-DNA double-strand break (DSB) complexes and rejoins the breaks. When TOP2-mediated ligation fails, ATM facilitates DSB repair. Following estrogen exposure, TOP2-dependent DSBs arise at the c-MYC enhancer in human BC cells, and their defective repair changes the activation profile of enhancers and induces the overexpression of many genes including the c-MYC oncogene. CRISPR/Cas9 cleavage at the enhancer also causes c-MYC overexpression, indicating that this DSB causes c-MYC overexpression. Estrogen treatment induced c-Myc protein overexpression in mammary epithelial cells of ATM-deficient mice. In conclusion, ATM suppresses the c-Myc-driven proliferative effects of estrogens, possibly explaining such tissue-specific oncogenesis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE218320 | GEO | 2023/06/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-01-31 | PXD033833 | Pride
2023-02-01 | GSE203435 | GEO
2024-01-26 | PXD046611 | Pride
2020-05-13 | MODEL2005130001 | BioModels
2017-11-30 | PXD005913 | Pride
2021-01-29 | E-MTAB-8851 | biostudies-arrayexpress
2023-11-17 | E-MTAB-10865 | biostudies-arrayexpress
2023-12-16 | GSE221266 | GEO
2019-12-23 | GSE133954 | GEO
| PRJNA903161 | ENA